158 related articles for article (PubMed ID: 21741079)
1. Laparoscopic-assisted cytoreduction for primary advanced ovarian cancer: success, morbidity and survival.
Fanning J; Yacoub E; Hojat R
Gynecol Oncol; 2011 Oct; 123(1):47-9. PubMed ID: 21741079
[TBL] [Abstract][Full Text] [Related]
2. Laparoscopic cytoreduction for primary advanced ovarian cancer.
Fanning J; Hojat R; Johnson J; Fenton B
JSLS; 2010; 14(1):80-2. PubMed ID: 20529532
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of laparoscopic debulking with electrosurgical loop excision procedure and argon beam coagulator at recurrence in patients with previous laparotomy debulking.
Trinh H; Ott C; Fanning J
Am J Obstet Gynecol; 2004 May; 190(5):1394-7. PubMed ID: 15167847
[TBL] [Abstract][Full Text] [Related]
4. Complete surgical cytoreduction of advanced ovarian carcinoma using the argon beam coagulator.
Bristow RE; Montz FJ
Gynecol Oncol; 2001 Oct; 83(1):39-48. PubMed ID: 11585412
[TBL] [Abstract][Full Text] [Related]
5. Laparoscopic treatment of early ovarian cancer: surgical and survival outcomes.
Tozzi R; Köhler C; Ferrara A; Schneider A
Gynecol Oncol; 2004 Apr; 93(1):199-203. PubMed ID: 15047236
[TBL] [Abstract][Full Text] [Related]
6. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.
Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Poynor EA; Aghajanian C; Jarnagin WR; DeMatteo RP; D'Angelica MI; Barakat RR; Chi DS
Gynecol Oncol; 2006 Dec; 103(3):1083-90. PubMed ID: 16890277
[TBL] [Abstract][Full Text] [Related]
7. The utility of hand-assisted laparoscopy in ovarian cancer.
Krivak TC; Elkas JC; Rose GS; Sundborg M; Winter WE; Carlson J; MacKoul PJ
Gynecol Oncol; 2005 Jan; 96(1):72-6. PubMed ID: 15589583
[TBL] [Abstract][Full Text] [Related]
8. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
[TBL] [Abstract][Full Text] [Related]
9. The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas.
Chi DS; Zivanovic O; Levinson KL; Kolev V; Huh J; Dottino J; Gardner GJ; Leitao MM; Levine DA; Sonoda Y; Abu-Rustum NR; Brown CL; Barakat RR
Gynecol Oncol; 2010 Oct; 119(1):38-42. PubMed ID: 20609464
[TBL] [Abstract][Full Text] [Related]
10. Feasibility and efficacy of laparoscopic management of ovarian cancer.
Jung US; Lee JH; Kyung MS; Choi JS
J Obstet Gynaecol Res; 2009 Feb; 35(1):113-8. PubMed ID: 19215557
[TBL] [Abstract][Full Text] [Related]
11. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR
Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134
[TBL] [Abstract][Full Text] [Related]
12. Laparoendoscopic single-site surgery (LESS) in gynecologic oncology: technique and initial report.
Fader AN; Escobar PF
Gynecol Oncol; 2009 Aug; 114(2):157-61. PubMed ID: 19481243
[TBL] [Abstract][Full Text] [Related]
13. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study.
Eisenkop SM; Friedman RL; Wang HJ
Gynecol Oncol; 1998 May; 69(2):103-8. PubMed ID: 9600815
[TBL] [Abstract][Full Text] [Related]
14. Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancer.
Zang RY; Zhang ZY; Li ZT; Cai SM; Tang MQ; Chen J; Liu Q
Eur J Surg Oncol; 2000 Dec; 26(8):798-804. PubMed ID: 11087649
[TBL] [Abstract][Full Text] [Related]
15. Transverse colectomy in ovarian cancer surgical cytoreduction: operative technique and clinical outcome.
Bristow RE; Peiretti M; Zanagnolo V; Salani R; Giuntoli RL; Maggioni A
Gynecol Oncol; 2008 Jun; 109(3):364-9. PubMed ID: 18396322
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease.
Hou JY; Kelly MG; Yu H; McAlpine JN; Azodi M; Rutherford TJ; Schwartz PE
Gynecol Oncol; 2007 Apr; 105(1):211-7. PubMed ID: 17239941
[TBL] [Abstract][Full Text] [Related]
17. The results of treatment of epithelial ovarian cancer after centralisation of primary surgery. Results from North Jutland, Denmark.
Soegaard Andersen E; Knudsen A; Svarrer T; Lund B; Nielsen K; Grove A; Tetsche M
Gynecol Oncol; 2005 Dec; 99(3):552-6. PubMed ID: 16150480
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy for unresectable ovarian carcinoma: a French multicenter study.
Ansquer Y; Leblanc E; Clough K; Morice P; Dauplat J; Mathevet P; Lhommé C; Scherer C; Tigaud JD; Benchaib M; Fourme E; Castaigne D; Querleu D; Dargent D
Cancer; 2001 Jun; 91(12):2329-34. PubMed ID: 11413522
[TBL] [Abstract][Full Text] [Related]
19. Laparoscopic intraperitoneal port placement for optimally cytoreduced advanced ovarian cancer.
Janco JM; Hacker MR; Konstantinopoulos PA; Cannistra SA; Awtrey CS
J Minim Invasive Gynecol; 2011; 18(5):629-33. PubMed ID: 21803662
[TBL] [Abstract][Full Text] [Related]
20. Laparoscopic restaging of borderline ovarian tumours: results of 30 cases initially presumed as stage IA borderline ovarian tumours.
Querleu D; Papageorgiou T; Lambaudie E; Sonoda Y; Narducci F; LeBlanc E
BJOG; 2003 Feb; 110(2):201-4. PubMed ID: 12618166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
